KR940006271B1 - 제약 조성물 - Google Patents

제약 조성물 Download PDF

Info

Publication number
KR940006271B1
KR940006271B1 KR1019900002250A KR900002250A KR940006271B1 KR 940006271 B1 KR940006271 B1 KR 940006271B1 KR 1019900002250 A KR1019900002250 A KR 1019900002250A KR 900002250 A KR900002250 A KR 900002250A KR 940006271 B1 KR940006271 B1 KR 940006271B1
Authority
KR
South Korea
Prior art keywords
ranitidine
pharmaceutical composition
weight
mixture
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019900002250A
Other languages
English (en)
Korean (ko)
Other versions
KR900012612A (ko
Inventor
쿠마 코프라 샴
태런 마카디아 트리브호반
Original Assignee
글락소 캐나다 인크.
데이빗 에이. 브라운
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글락소 캐나다 인크., 데이빗 에이. 브라운 filed Critical 글락소 캐나다 인크.
Publication of KR900012612A publication Critical patent/KR900012612A/ko
Application granted granted Critical
Publication of KR940006271B1 publication Critical patent/KR940006271B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019900002250A 1989-02-23 1990-02-22 제약 조성물 Expired - Lifetime KR940006271B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB89-04182.6 1989-02-23
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions
GB8904182.6 1989-02-23

Publications (2)

Publication Number Publication Date
KR900012612A KR900012612A (ko) 1990-09-01
KR940006271B1 true KR940006271B1 (ko) 1994-07-14

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900002250A Expired - Lifetime KR940006271B1 (ko) 1989-02-23 1990-02-22 제약 조성물

Country Status (26)

Country Link
US (1) US5028432A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2856817B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR940006271B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT401727B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU629303B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1003123A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2010692C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH680567A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1734A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4005650C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK170209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2643263B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8904182D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK89493A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU211930A9 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE63179B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL93490A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1240768B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU87681A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL193267C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ232642A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH26972A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA90100287B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE512412C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA901348B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW1790A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
JP2006518380A (ja) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
ES2445947T3 (es) 2003-08-13 2014-03-06 Biocon Limited Formulaciones para dosificación de sólidos de sales de ácidos grasos en forma de micropartículas para agentes terapéuticos
SG185631A1 (en) 2010-06-23 2012-12-28 Colgate Palmolive Co Therapeutic oral composition
US9289369B2 (en) 2010-12-20 2016-03-22 Colgate-Palmolive Company Non-aqueous oral care composition containing dental occlusion actives
SG190859A1 (en) 2010-12-20 2013-07-31 Colgate Palmolive Co Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
JP2014501241A (ja) 2010-12-20 2014-01-20 コルゲート・パーモリブ・カンパニー 歯科用閉塞活性剤、疎水性粘度調整剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
RU2761346C2 (ru) * 2016-11-01 2021-12-07 Джонсон энд Джонсон Консьюмер Инк. Жидкая пероральная фармацевтическая лекарственная форма, содержащая антагонист h2-рецептора гистамина и антацид
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
WO2020051585A1 (en) * 2018-09-07 2020-03-12 R.P. Scherer Technologies, Llc Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
BE896711A (fr) * 1982-05-14 1983-09-01 Richter Gedeon Vegyeszet Compositions pharmaceutiques anti-ulceres.
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
EP0152432B1 (en) * 1983-08-01 1989-03-01 R.P. Scherer Corporation Sustained release method and product
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
JPH0482832A (ja) * 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物

Also Published As

Publication number Publication date
SA90100287B1 (ar) 1999-08-15
ZA901348B (en) 1991-03-27
NL9000428A (nl) 1990-09-17
NZ232642A (en) 1992-07-28
NL193267B (nl) 1999-01-04
FR2643263A1 (fr) 1990-08-24
CA2010692C (en) 1995-12-12
US5028432A (en) 1991-07-02
PH26972A (en) 1992-12-28
GB2229094B (en) 1993-01-06
DE4005650C2 (de) 1999-03-25
BE1003123A3 (fr) 1991-12-03
DK48090A (da) 1990-08-24
IL93490A (en) 1994-07-31
CH680567A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-09-30
JP2856817B2 (ja) 1999-02-10
GB2229094A (en) 1990-09-19
LU87681A1 (fr) 1991-10-08
SE9000625D0 (sv) 1990-02-22
AU5007390A (en) 1990-08-30
ATA42190A (de) 1996-04-15
SE9000625L (sv) 1990-08-24
SE512412C2 (sv) 2000-03-13
IT9047659A0 (it) 1990-02-22
DK48090D0 (da) 1990-02-22
IE900651L (en) 1990-08-23
AT401727B (de) 1996-11-25
IT9047659A1 (it) 1991-08-22
JPH03200728A (ja) 1991-09-02
HU211930A9 (en) 1996-01-29
FR2643263B1 (fr) 1994-09-16
DK170209B1 (da) 1995-06-19
GB9004016D0 (en) 1990-04-18
IE63179B1 (en) 1995-03-22
HK89493A (en) 1993-09-03
IL93490A0 (en) 1990-11-29
ZW1790A1 (en) 1991-10-16
CY1734A (en) 1994-05-06
GB8904182D0 (en) 1989-04-05
NL193267C (nl) 1999-05-06
KR900012612A (ko) 1990-09-01
AU629303B2 (en) 1992-10-01
IT1240768B (it) 1993-12-17
DE4005650A1 (de) 1990-09-06
CA2010692A1 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
KR940006271B1 (ko) 제약 조성물
KR930008955B1 (ko) 비타민류, 식이요법용 보충물등을 함유하는 연질젤용 에탄올 충전제제
PT2279729T (pt) Preparações de libertação controlada
CZ290314B6 (cs) Kapalinou plněná měkká ľelatinová kapsle a způsob její výroby
WO1995016438A1 (en) Biphasic capsule formulation
CA1250526A (en) Hot melt antihistamine formulations
JPH0816051B2 (ja) 徐放性坐剤
AU1168099A (en) Formulations comprising dissolved paroxetine
WO1999006031A1 (en) Pharmaceutical formulation for camptothecin analogues in gelatin capsule
US20020032220A1 (en) Formulations comprising dissolved paroxetine
CA2231545C (en) Oral gel capsule formulation of 1,2,4-benzotriazine oxides
US20100221326A1 (en) Pharmaceutical compositions for oral use for treating patients affected by obesity
EP0431659B1 (en) Pharmaceutical compositions of tebufelone
CA2179041C (en) Biphasic capsule formulation
CA2310407A1 (en) Formulations comprising dissolved paroxetine
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin
MXPA06000100A (en) Controlled release preparations

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900222

PG1501 Laying open of application
AMND Amendment
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19911123

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900222

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19930916

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19940304

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19930916

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19940926

Appeal identifier: 1994201000639

Request date: 19940406

PB0901 Examination by re-examination before a trial

Comment text: Request for Trial against Decision on Refusal

Patent event date: 19940406

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 19931216

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 19911123

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 19910319

Patent event code: PB09011R02I

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19940620

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 19940926

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 19940610

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19941025

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19941025

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19970708

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19970830

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19990705

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20000707

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20010705

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20020709

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20030701

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20040701

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20050630

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20060630

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20070702

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20080630

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20090630

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20090630

Start annual number: 16

End annual number: 16

EXPY Expiration of term
PC1801 Expiration of term